Originally published by our sister publication Pain Medicine News.
New research has found that increased access to the opioid use disorder (OUD) drug methadone at the start of the COVID-19 pandemic may have been behind a reduction in methadone-related overdose deaths over a more than two-year period.
Due to efforts to limit the spread of COVID-19, methadone access was expanded to permit more OUD patients to take doses at home. In the United States, methadone treatment for OUD usually has required